The plasma level of omentin was found to be lowered in patients with obesity, impaired glucose tolerance, and type 2 diabetes mellitus, of which the diabetic patients had the lowest level of omentin, compared to control [13,14,15]. Here, ITLN1 is linked to obesity due to melanocortin 4 receptor deficiency.